| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.954 | 0.002 | 0.954 | Dopamine D4 antagonist | 0.794 0.003 CID_10114519 0.758 0.003 CID_9847259 0.288 0.008 CID_851833 | ||
| 0.896 | 0.003 | 0.896 | Dopamine D2 antagonist | 0.708 0.004 CID_10114519 0.858 0.003 CID_9847259 0.266 0.012 CID_851833 | ||
| 0.886 | 0.003 | 0.886 | Dopamine antagonist | 0.711 0.004 CID_10114519 0.848 0.003 CID_9847259 0.304 0.011 CID_851833 | ||
| 0.83 | 0.003 | 0.83 | 5 Hydroxytryptamine 1A antagonist | 0.628 0.004 CID_10114519 0.54 0.004 CID_9847259 0.297 0.009 CID_851833 | ||
| 0.823 | 0.003 | 0.823 | 5 Hydroxytryptamine 2 antagonist | 0.713 0.004 CID_10114519 0.643 0.004 CID_9847259 0.433 0.008 CID_851833 | ||
| 0.817 | 0.003 | 0.817 | Alpha 1 adrenoreceptor antagonist | 0.582 0.004 CID_10114519 0.664 0.004 CID_9847259 0.329 0.009 CID_851833 | ||
| 0.813 | 0.004 | 0.813 | 5 Hydroxytryptamine antagonist | 0.675 0.004 CID_10114519 0.605 0.005 CID_9847259 0.48 0.008 CID_851833 | ||
| 0.81 | 0.003 | 0.81 | Alpha adrenoreceptor antagonist | 0.536 0.005 CID_10114519 0.676 0.004 CID_9847259 0.377 0.01 CID_851833 | ||
| 0.782 | 0.003 | 0.782 | 5 Hydroxytryptamine 2A antagonist | 0.671 0.003 CID_10114519 0.562 0.004 CID_9847259 0.072 0.065 CID_56851120 0.379 0.008 CID_851833 | ||
| 0.779 | 0.003 | 0.779 | 5 Hydroxytryptamine 1 antagonist | 0.596 0.004 CID_10114519 0.594 0.004 CID_9847259 0.298 0.01 CID_851833 | ||
| 0.769 | 0.003 | 0.769 | Alpha 1a adrenoreceptor antagonist | 0.513 0.004 CID_10114519 0.62 0.004 CID_9847259 0.3 0.009 CID_851833 | ||
| 0.696 | 0.001 | 0.696 | Dopamine autoreceptor agonist | 0.559 0.001 CID_10114519 0.484 0.002 CID_9847259 0.171 0.003 CID_56851120 0.052 0.007 CID_851833 | ||
| 0.698 | 0.004 | 0.773 | Dopamine agonist | 0.648 0.004 CID_10114519 0.667 0.004 CID_9847259 0.104 0.026 CID_56851120 0.773 0.003 CID_851833 | CID_851833 | |
| 0.694 | 0.004 | 0.694 | 5 Hydroxytryptamine 2B antagonist | 0.571 0.004 CID_10114519 0.554 0.005 CID_9847259 0.35 0.011 CID_851833 | ||
| 0.687 | 0.003 | 0.694 | Dopamine D2 agonist | 0.626 0.003 CID_10114519 0.656 0.003 CID_9847259 0.125 0.008 CID_56851120 0.694 0.003 CID_851833 | CID_851833 | |
| 0.617 | 0.004 | 0.617 | 5 Hydroxytryptamine 2C antagonist | 0.587 0.004 CID_10114519 0.315 0.008 CID_9847259 0.412 0.005 CID_851833 | ||
| 0.588 | 0.003 | 0.588 | Alpha 1b adrenoreceptor antagonist | 0.367 0.005 CID_10114519 0.436 0.004 CID_9847259 0.243 0.011 CID_851833 | ||
| 0.6 | 0.016 | 0.6 | Vasodilator, peripheral | 0.562 0.02 CID_10114519 0.502 0.027 CID_9847259 0.354 0.072 CID_56851120 0.375 0.064 CID_851833 | ||
| 0.545 | 0.009 | 0.545 | Anticonvulsant | 0.333 0.032 CID_10114519 0.307 0.039 CID_9847259 0.341 0.031 CID_851833 | ||
| 0.535 | 0.003 | 0.535 | Dopamine D3 antagonist | 0.424 0.004 CID_10114519 0.351 0.005 CID_9847259 0.231 0.009 CID_851833 | ||
| 0.523 | 0.002 | 0.523 | 5 Hydroxytryptamine 7 agonist | 0.256 0.003 CID_10114519 0.321 0.003 CID_9847259 0.07 0.019 CID_56851120 0.142 0.004 CID_851833 | ||
| 0.513 | 0.003 | 0.858 | Dopamine D3 agonist | 0.499 0.003 CID_10114519 0.41 0.003 CID_9847259 0.858 0.002 CID_851833 | CID_851833 | |
| 0.483 | 0.004 | 0.56 | 5 Hydroxytryptamine 1A agonist | 0.468 0.004 CID_10114519 0.368 0.005 CID_9847259 0.56 0.004 CID_851833 | CID_851833 | |
| 0.475 | 0.005 | 0.664 | 5 Hydroxytryptamine 7 antagonist | 0.448 0.005 CID_10114519 0.318 0.005 CID_9847259 0.664 0.004 CID_851833 | CID_851833 | |
| 0.475 | 0.007 | 0.475 | Calcium channel activator | 0.418 0.019 CID_10114519 0.437 0.014 CID_9847259 0.377 0.034 CID_56851120 0.425 0.017 CID_851833 | ||
| 0.467 | 0.004 | 0.521 | Dopamine D1 antagonist | 0.31 0.005 CID_10114519 0.521 0.003 CID_9847259 0.26 0.007 CID_851833 | CID_9847259 | |
| 0.442 | 0.004 | 0.605 | Dopamine D4 agonist | 0.381 0.004 CID_10114519 0.343 0.004 CID_9847259 0.605 0.003 CID_851833 | CID_851833 | |
| 0.437 | 0.007 | 0.551 | Antiadrenergic | 0.376 0.009 CID_10114519 0.377 0.009 CID_9847259 0.551 0.005 CID_851833 | CID_851833 | |
| 0.434 | 0.007 | 0.548 | Adrenaline antagonist | 0.372 0.009 CID_10114519 0.374 0.009 CID_9847259 0.548 0.005 CID_851833 | CID_851833 | |
| 0.387 | 0.004 | 0.387 | Alpha 1d adrenoreceptor antagonist | 0.191 0.01 CID_10114519 0.226 0.008 CID_9847259 0.167 0.012 CID_851833 | ||
| 0.393 | 0.018 | 0.393 | Cyclic AMP phosphodiesterase inhibitor | 0.371 0.021 CID_10114519 0.328 0.032 CID_9847259 0.368 0.022 CID_56851120 0.182 0.109 CID_851833 | ||
| 0.371 | 0.005 | 0.371 | Alpha 2b adrenoreceptor antagonist | 0.231 0.018 CID_10114519 0.231 0.018 CID_9847259 0.284 0.01 CID_851833 | ||
| 0.371 | 0.005 | 0.429 | 5 Hydroxytryptamine 1 agonist | 0.361 0.005 CID_10114519 0.285 0.007 CID_9847259 0.429 0.005 CID_851833 | CID_851833 | |
| 0.369 | 0.004 | 0.369 | 5 Hydroxytryptamine 1B antagonist | 0.251 0.006 CID_10114519 0.242 0.006 CID_9847259 0.187 0.009 CID_851833 | ||
| 0.422 | 0.067 | 0.515 | Calcium channel L-type activator | 0.262 0.193 CID_10114519 0.435 0.059 CID_9847259 0.515 0.022 CID_56851120 | CID_56851120 | |
| 0.372 | 0.027 | 0.372 | Psychostimulant | 0.194 0.083 CID_10114519 0.244 0.061 CID_9847259 0.22 0.07 CID_56851120 0.284 0.047 CID_851833 | ||
| 0.347 | 0.004 | 0.347 | 5 Hydroxytryptamine 5A antagonist | 0.25 0.004 CID_10114519 0.151 0.007 CID_9847259 0.195 0.005 CID_851833 | ||
| 0.402 | 0.077 | 0.469 | 5 Hydroxytryptamine release inhibitor | 0.469 0.044 CID_10114519 0.318 0.146 CID_9847259 0.345 0.119 CID_56851120 0.429 0.062 CID_851833 | CID_10114519 | |
| 0.325 | 0.006 | 0.325 | Alpha 2a adrenoreceptor antagonist | 0.213 0.012 CID_10114519 0.187 0.016 CID_9847259 0.318 0.006 CID_851833 | ||
| 0.308 | 0.006 | 0.308 | NMDA receptor antagonist | 0.244 0.01 CID_10114519 0.273 0.008 CID_9847259 0.205 0.014 CID_851833 | ||
| 0.334 | 0.033 | 0.334 | Sigma receptor agonist | 0.237 0.051 CID_10114519 0.227 0.054 CID_9847259 0.152 0.084 CID_851833 | ||
| 0.296 | 0.008 | 0.639 | 5 Hydroxytryptamine agonist | 0.242 0.011 CID_10114519 0.215 0.013 CID_9847259 0.639 0.004 CID_851833 | CID_851833 | |
| 0.288 | 0.004 | 0.288 | 5 Hydroxytryptamine 5 antagonist | 0.218 0.005 CID_10114519 0.129 0.01 CID_9847259 0.186 0.005 CID_851833 | ||
| 0.283 | 0.005 | 0.283 | 5 Hydroxytryptamine 1D antagonist | 0.21 0.006 CID_10114519 0.177 0.008 CID_9847259 0.164 0.01 CID_851833 | ||
| 0.279 | 0.008 | 0.279 | Histamine H1 receptor antagonist | 0.209 0.013 CID_10114519 0.135 0.028 CID_9847259 0.099 0.042 CID_851833 | ||
| 0.265 | 0.009 | 0.265 | Alpha 2c adrenoreceptor antagonist | 0.17 0.025 CID_10114519 0.168 0.025 CID_9847259 0.218 0.015 CID_851833 | ||
| 0.267 | 0.012 | 0.267 | Antihistaminic | 0.259 0.013 CID_10114519 0.094 0.06 CID_9847259 0.098 0.056 CID_851833 | ||
| 0.298 | 0.05 | 0.491 | Potassium channel (Voltage-sensitive) blocker | 0.329 0.041 CID_10114519 0.16 0.129 CID_9847259 0.491 0.015 CID_851833 | CID_851833 | |
| 0.259 | 0.012 | 0.259 | Histamine antagonist | 0.253 0.013 CID_10114519 0.082 0.061 CID_9847259 0.089 0.055 CID_851833 | ||
| 0.263 | 0.022 | 0.263 | Acetylcholine M1 receptor antagonist | 0.257 0.023 CID_10114519 0.223 0.033 CID_9847259 0.194 0.045 CID_851833 | ||
| 0.29 | 0.052 | 0.528 | HERG channel blocker | 0.346 0.038 CID_10114519 0.163 0.117 CID_9847259 0.528 0.013 CID_851833 | CID_851833 | |
| 0.278 | 0.046 | 0.332 | 5 Hydroxytryptamine 1E antagonist | 0.255 0.069 CID_10114519 0.202 0.128 CID_9847259 0.332 0.015 CID_851833 | CID_851833 | |
| 0.235 | 0.013 | 0.255 | Alpha 2 adrenoreceptor antagonist | 0.146 0.028 CID_10114519 0.168 0.023 CID_9847259 0.255 0.011 CID_851833 | CID_851833 | |
| 0.266 | 0.044 | 0.268 | ErbB-1 antagonist | 0.268 0.044 CID_10114519 0.246 0.053 CID_9847259 0.226 0.066 CID_56851120 0.162 0.149 CID_851833 | CID_10114519 | |
| 0.291 | 0.095 | 0.291 | Vasodilator, coronary | 0.239 0.145 CID_10114519 0.291 0.095 CID_9847259 0.26 0.124 CID_56851120 0.246 0.139 CID_851833 | ||
| 0.267 | 0.077 | 0.267 | Ca(v)3.3 blocker | 0.262 0.083 CID_10114519 0.235 0.125 CID_9847259 | ||
| 0.25 | 0.059 | 0.336 | MAP-kinase-activated kinase 5 inhibitor | 0.287 0.037 CID_10114519 0.22 0.082 CID_9847259 0.336 0.014 CID_851833 | CID_851833 | |
| 0.248 | 0.058 | 0.282 | Neuropeptide Y2 antagonist | 0.211 0.101 CID_10114519 0.193 0.132 CID_9847259 0.282 0.029 CID_851833 | CID_851833 | |
| 0.186 | 0.011 | 0.186 | NMDA 2 receptor antagonist | 0.153 0.016 CID_10114519 0.116 0.025 CID_9847259 0.138 0.019 CID_851833 | ||
| 0.294 | 0.12 | 0.547 | GABA C receptor rho-3 antagonist | 0.427 0.05 CID_10114519 0.256 0.149 CID_9847259 0.333 0.095 CID_56851120 0.547 0.015 CID_851833 | CID_851833 | |
| 0.18 | 0.007 | 0.18 | Alpha 1 adrenoreceptor agonist | 0.105 0.015 CID_10114519 0.103 0.016 CID_9847259 0.141 0.01 CID_851833 | ||
| 0.183 | 0.027 | 0.183 | Neuropeptide Y1 antagonist | 0.143 0.075 CID_10114519 0.147 0.069 CID_9847259 0.133 0.094 CID_56851120 0.172 0.037 CID_851833 | ||
| 0.17 | 0.014 | 0.506 | 5 Hydroxytryptamine uptake inhibitor | 0.173 0.013 CID_10114519 0.11 0.023 CID_9847259 0.506 0.004 CID_851833 | CID_851833 | |
| 0.327 | 0.178 | 0.477 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.307 0.203 CID_10114519 0.372 0.127 CID_56851120 0.477 0.045 CID_851833 | CID_851833 | |
| 0.163 | 0.014 | 0.22 | Alpha adrenoreceptor agonist | 0.086 0.034 CID_10114519 0.086 0.034 CID_9847259 0.22 0.007 CID_851833 | CID_851833 | |
| 0.157 | 0.009 | 0.157 | Acetylcholine M4 receptor antagonist | 0.078 0.048 CID_10114519 0.092 0.035 CID_9847259 0.109 0.022 CID_851833 | ||
| 0.232 | 0.093 | 0.273 | Interleukin agonist | 0.224 0.099 CID_9847259 0.273 0.063 CID_851833 | CID_851833 | |
| 0.211 | 0.074 | 0.211 | Platelet aggregation inhibitor | 0.211 0.074 CID_10114519 0.164 0.113 CID_56851120 | ||
| 0.14 | 0.009 | 0.143 | Acetylcholine M5 receptor antagonist | 0.143 0.008 CID_10114519 0.104 0.016 CID_9847259 0.081 0.024 CID_851833 | CID_10114519 | |
| 0.151 | 0.028 | 0.201 | Mediator release inhibitor | 0.201 0.014 CID_10114519 0.176 0.019 CID_9847259 | CID_10114519 | |
| 0.129 | 0.008 | 0.17 | 5 Hydroxytryptamine 2A agonist | 0.112 0.011 CID_10114519 0.076 0.031 CID_9847259 0.056 0.051 CID_56851120 0.17 0.004 CID_851833 | CID_851833 | |
| 0.222 | 0.104 | 0.243 | Spasmolytic | 0.243 0.094 CID_9847259 | CID_9847259 | |
| 0.163 | 0.05 | 0.21 | Nav1.2 sodium channel blocker | 0.21 0.031 CID_10114519 0.127 0.075 CID_851833 | CID_10114519 | |
| 0.146 | 0.035 | 0.146 | Nav1.1 sodium channel blocker | 0.118 0.049 CID_10114519 0.12 0.048 CID_9847259 | ||
| 0.193 | 0.082 | 0.269 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.236 0.056 CID_10114519 0.181 0.093 CID_9847259 0.269 0.045 CID_851833 | CID_851833 | |
| 0.131 | 0.021 | 0.165 | Adrenaline agonist | 0.164 0.012 CID_10114519 0.165 0.012 CID_9847259 0.091 0.044 CID_851833 | CID_9847259 | |
| 0.155 | 0.048 | 0.19 | Glutamate receptor antagonist | 0.147 0.053 CID_10114519 0.147 0.053 CID_9847259 0.19 0.029 CID_851833 | CID_851833 | |
| 0.19 | 0.082 | 0.271 | 5 Hydroxytryptamine 3E antagonist | 0.2 0.062 CID_10114519 0.192 0.078 CID_56851120 0.271 0.009 CID_851833 | CID_851833 | |
| 0.149 | 0.044 | 0.153 | Acetylcholine muscarinic antagonist | 0.137 0.052 CID_10114519 0.153 0.042 CID_9847259 0.108 0.081 CID_851833 | CID_9847259 | |
| 0.199 | 0.093 | 0.289 | Potassium channel blocker | 0.213 0.084 CID_10114519 0.289 0.05 CID_851833 | CID_851833 | |
| 0.141 | 0.036 | 0.186 | EphA2 antagonist | 0.148 0.031 CID_10114519 0.097 0.079 CID_9847259 0.186 0.017 CID_851833 | CID_851833 | |
| 0.149 | 0.048 | 0.164 | Nav1.3 sodium channel blocker | 0.164 0.039 CID_10114519 0.135 0.059 CID_851833 | CID_10114519 | |
| 0.126 | 0.026 | 0.14 | Histamine N-methyltransferase inhibitor | 0.137 0.019 CID_10114519 0.084 0.062 CID_9847259 0.14 0.018 CID_851833 | CID_851833 | |
| 0.119 | 0.024 | 0.268 | 5 Hydroxytryptamine 1F antagonist | 0.1 0.031 CID_10114519 0.075 0.046 CID_9847259 0.268 0.007 CID_851833 | CID_851833 | |
| 0.108 | 0.019 | 0.164 | Phosphodiesterase III inhibitor | 0.139 0.012 CID_10114519 0.093 0.026 CID_9847259 0.164 0.009 CID_56851120 | CID_56851120 | |
| 0.177 | 0.091 | 0.191 | Focal adhesion kinase 2 inhibitor | 0.191 0.076 CID_56851120 0.163 0.11 CID_851833 | CID_56851120 | |
| 0.129 | 0.043 | 0.129 | Butyrylcholinesterase inhibitor | 0.11 0.054 CID_10114519 0.122 0.046 CID_9847259 | ||
| 0.144 | 0.06 | 0.283 | Toll-Like receptor antagonist | 0.26 0.013 CID_10114519 0.148 0.057 CID_9847259 0.283 0.009 CID_851833 | CID_851833 | |
| 0.099 | 0.016 | 0.113 | NMDA 2C receptor antagonist | 0.064 0.039 CID_10114519 0.076 0.028 CID_9847259 0.113 0.012 CID_851833 | CID_851833 | |
| 0.154 | 0.074 | 0.209 | Cholinergic | 0.13 0.096 CID_10114519 0.142 0.084 CID_9847259 0.209 0.042 CID_56851120 | CID_56851120 | |
| 0.139 | 0.059 | 0.139 | Cholinergic antagonist | 0.134 0.062 CID_10114519 0.132 0.063 CID_9847259 0.116 0.078 CID_851833 | ||
| 0.137 | 0.058 | 0.137 | Acetylcholine antagonist | 0.133 0.06 CID_10114519 0.13 0.062 CID_9847259 0.114 0.076 CID_851833 | ||
| 0.087 | 0.009 | 0.241 | Nicotinic acid receptor 1 agonist | 0.241 0.003 CID_10114519 0.064 0.015 CID_9847259 0.195 0.004 CID_851833 | CID_10114519 | |
| 0.113 | 0.036 | 0.121 | Interleukin 12 antagonist | 0.085 0.084 CID_10114519 0.114 0.035 CID_9847259 0.121 0.028 CID_56851120 | CID_56851120 | |
| 0.094 | 0.017 | 0.094 | Sigma receptor antagonist | 0.061 0.027 CID_10114519 0.063 0.026 CID_9847259 0.046 0.037 CID_851833 | ||
| 0.21 | 0.134 | 0.268 | Gastrin inhibitor | 0.268 0.06 CID_10114519 0.222 0.116 CID_851833 | CID_10114519 | |
| 0.138 | 0.063 | 0.205 | Acetylcholinesterase inhibitor | 0.131 0.069 CID_10114519 0.13 0.069 CID_9847259 0.205 0.032 CID_56851120 | CID_56851120 | |
| 0.167 | 0.093 | 0.167 | P-glycoprotein inhibitor | 0.15 0.117 CID_10114519 0.165 0.096 CID_9847259 | ||
| 0.086 | 0.014 | 0.149 | Phosphodiesterase 3B inhibitor | 0.094 0.012 CID_10114519 0.08 0.015 CID_9847259 0.149 0.006 CID_56851120 | CID_56851120 | |
| 0.098 | 0.029 | 0.167 | Cyclin B3 inhibitor | 0.082 0.037 CID_10114519 0.104 0.027 CID_9847259 0.059 0.058 CID_56851120 0.167 0.01 CID_851833 | CID_851833 | |
| 0.081 | 0.012 | 0.081 | 5 Hydroxytryptamine 1B agonist | 0.079 0.013 CID_10114519 0.069 0.018 CID_9847259 0.07 0.018 CID_56851120 0.056 0.032 CID_851833 | ||
| 0.093 | 0.024 | 0.093 | Acetylcholine M5 receptor agonist | 0.072 0.041 CID_10114519 0.088 0.027 CID_56851120 0.092 0.025 CID_851833 | ||
| 0.16 | 0.092 | 0.258 | Lipocortins synthesis antagonist | 0.17 0.08 CID_9847259 0.258 0.031 CID_56851120 | CID_56851120 | |
| 0.133 | 0.068 | 0.133 | MAO inhibitor | 0.119 0.075 CID_9847259 0.125 0.072 CID_56851120 | ||
| 0.183 | 0.119 | 0.222 | Vasodilator | 0.154 0.151 CID_10114519 0.203 0.102 CID_9847259 0.222 0.088 CID_56851120 | CID_56851120 | |
| 0.076 | 0.015 | 0.076 | 5 Hydroxytryptamine 4 antagonist | 0.06 0.024 CID_10114519 0.059 0.024 CID_9847259 0.067 0.019 CID_851833 | ||
| 0.076 | 0.017 | 0.221 | 5 Hydroxytryptamine 2 agonist | 0.049 0.039 CID_10114519 0.056 0.032 CID_9847259 0.221 0.004 CID_851833 | CID_851833 | |
| 0.163 | 0.106 | 0.185 | MAP kinase kinase 5 inhibitor | 0.162 0.109 CID_10114519 0.152 0.146 CID_9847259 0.185 0.054 CID_56851120 | CID_56851120 | |
| 0.068 | 0.014 | 0.081 | Alpha 1L adrenoreceptor antagonist | 0.081 0.007 CID_10114519 0.064 0.017 CID_9847259 | CID_10114519 | |
| 0.069 | 0.015 | 0.082 | Dopamine D5 antagonist | 0.054 0.023 CID_10114519 0.082 0.012 CID_9847259 0.037 0.035 CID_851833 | CID_9847259 | |
| 0.08 | 0.031 | 0.163 | 5 Hydroxytryptamine 3A antagonist | 0.081 0.03 CID_10114519 0.163 0.004 CID_851833 | CID_851833 | |
| 0.1 | 0.051 | 0.102 | Phosphodiesterase 6D inhibitor | 0.088 0.082 CID_10114519 0.098 0.057 CID_9847259 0.102 0.048 CID_56851120 | CID_56851120 | |
| 0.272 | 0.226 | 0.39 | Caspase 9 stimulant | 0.252 0.251 CID_10114519 0.355 0.142 CID_9847259 0.39 0.117 CID_56851120 0.328 0.165 CID_851833 | CID_56851120 | |
| 0.109 | 0.066 | 0.3 | 5 Hydroxytryptamine 3A agonist | 0.133 0.046 CID_10114519 0.3 0.004 CID_851833 | CID_851833 | |
| 0.099 | 0.06 | 0.099 | MAO B inhibitor | 0.092 0.065 CID_9847259 0.088 0.068 CID_56851120 | ||
| 0.106 | 0.068 | 0.142 | Protein kinase C gamma inhibitor | 0.116 0.056 CID_10114519 0.128 0.046 CID_56851120 0.142 0.037 CID_851833 | CID_851833 | |
| 0.074 | 0.036 | 0.284 | Purinergic P2 antagonist | 0.081 0.032 CID_10114519 0.284 0.005 CID_851833 | CID_851833 | |
| 0.095 | 0.058 | 0.108 | Toll-Like receptor 3 antagonist | 0.108 0.04 CID_10114519 0.094 0.061 CID_56851120 | CID_10114519 | |
| 0.107 | 0.072 | 0.141 | Nav1.5 sodium channel blocker | 0.111 0.067 CID_10114519 0.141 0.033 CID_851833 | CID_851833 | |
| 0.177 | 0.143 | 0.177 | Cardiotonic | |||
| 0.098 | 0.064 | 0.098 | Insulin receptor antagonist | 0.093 0.071 CID_851833 | ||
| 0.217 | 0.183 | 0.318 | Histamine release inhibitor | 0.207 0.194 CID_10114519 0.224 0.177 CID_9847259 0.318 0.115 CID_56851120 | CID_56851120 | |
| 0.056 | 0.023 | 0.133 | Oleamide hydrolase inhibitor | 0.133 0.005 CID_10114519 0.042 0.035 CID_56851120 0.053 0.025 CID_851833 | CID_10114519 | |
| 0.193 | 0.16 | 0.2 | Thyroid hormone beta antagonist | 0.2 0.153 CID_9847259 | CID_9847259 | |
| 0.062 | 0.029 | 0.062 | Melanin-concentrating hormone receptor 1 antagonist | 0.053 0.037 CID_10114519 | ||
| 0.134 | 0.101 | 0.141 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.141 0.095 CID_10114519 0.128 0.108 CID_9847259 | CID_10114519 | |
| 0.056 | 0.023 | 0.077 | Histamine H3 receptor antagonist | 0.077 0.017 CID_10114519 | CID_10114519 | |
| 0.07 | 0.039 | 0.082 | MDM2 inhibitor | 0.073 0.03 CID_10114519 0.082 0.018 CID_851833 | CID_851833 | |
| 0.195 | 0.166 | 0.212 | Thyroid hormone antagonist | 0.212 0.151 CID_9847259 | CID_9847259 | |
| 0.128 | 0.099 | 0.128 | MAP3K9 inhibitor | 0.125 0.105 CID_9847259 0.123 0.108 CID_56851120 | ||
| 0.09 | 0.064 | 0.175 | Protein kinase C zeta inhibitor | 0.1 0.05 CID_10114519 0.094 0.059 CID_9847259 0.175 0.015 CID_851833 | CID_851833 | |
| 0.072 | 0.046 | 0.126 | Amidase inhibitor | 0.126 0.014 CID_10114519 0.111 0.019 CID_851833 | CID_10114519 | |
| 0.152 | 0.131 | 0.152 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.032 | 0.012 | 0.035 | DNA polymerase III inhibitor | 0.035 0.008 CID_10114519 0.027 0.024 CID_9847259 | CID_10114519 | |
| 0.08 | 0.061 | 0.085 | Acetylcholine M3 receptor agonist | 0.085 0.056 CID_56851120 | CID_56851120 | |
| 0.077 | 0.059 | 0.101 | Platelet growth factor antagonist | 0.101 0.04 CID_10114519 | CID_10114519 | |
| 0.041 | 0.023 | 0.166 | 5 Hydroxytryptamine 2B agonist | 0.166 0.003 CID_851833 | CID_851833 | |
| 0.039 | 0.023 | 0.041 | Delayed rectifier potassium channel blocker | 0.041 0.02 CID_10114519 | CID_10114519 | |
| 0.084 | 0.069 | 0.104 | ATPase (Vacuolar H+) inhibitor | 0.104 0.035 CID_10114519 | CID_10114519 | |
| 0.038 | 0.023 | 0.186 | Purinergic P2X7 antagonist | 0.034 0.027 CID_10114519 0.186 0.003 CID_851833 | CID_851833 | |
| 0.063 | 0.048 | 0.071 | Beta 3 adrenoreceptor antagonist | 0.066 0.041 CID_10114519 0.071 0.032 CID_9847259 0.061 0.052 CID_56851120 | CID_9847259 | |
| 0.064 | 0.05 | 0.065 | Bcl2 antagonist | 0.065 0.048 CID_10114519 0.059 0.057 CID_851833 | CID_10114519 | |
| 0.059 | 0.045 | 0.255 | Adrenaline uptake inhibitor | 0.055 0.05 CID_10114519 0.255 0.005 CID_851833 | CID_851833 | |
| 0.201 | 0.188 | 0.234 | Interleukin 2 agonist | 0.224 0.151 CID_9847259 0.234 0.137 CID_56851120 | CID_56851120 | |
| 0.068 | 0.055 | 0.071 | Calcium channel L-type blocker | 0.071 0.05 CID_10114519 | CID_10114519 | |
| 0.095 | 0.083 | 0.102 | Platelet activating factor antagonist | 0.102 0.076 CID_10114519 | CID_10114519 | |
| 0.085 | 0.075 | 0.134 | MAO A inhibitor | 0.093 0.069 CID_9847259 0.134 0.046 CID_56851120 | CID_56851120 | |
| 0.035 | 0.025 | 0.035 | Adenosine uptake inhibitor | |||
| 0.074 | 0.065 | 0.091 | Phosphodiesterase 3A inhibitor | 0.089 0.043 CID_10114519 0.091 0.04 CID_56851120 | CID_56851120 | |
| 0.043 | 0.034 | 0.319 | 5 Hydroxytryptamine 2C agonist | 0.319 0.003 CID_851833 | CID_851833 | |
| 0.056 | 0.048 | 0.056 | Acetylcholine M2 receptor antagonist | |||
| 0.045 | 0.038 | 0.224 | Purinergic P2X antagonist | 0.045 0.038 CID_10114519 0.224 0.004 CID_851833 | CID_851833 | |
| 0.052 | 0.045 | 0.176 | 5 Hydroxytryptamine 3 antagonist | 0.176 0.007 CID_851833 | CID_851833 | |
| 0.018 | 0.011 | 0.025 | 5-Alpha-reductase 1 inhibitor | 0.025 0.01 CID_56851120 | CID_56851120 | |
| 0.013 | 0.01 | 0.015 | DNA polymerase III polC-type inhibitor | 0.015 0.006 CID_10114519 | CID_10114519 | |
| 0.053 | 0.05 | 0.067 | Acetylcholine M3 receptor antagonist | 0.067 0.034 CID_9847259 | CID_9847259 | |
| 0.061 | 0.064 | 0.073 | CXC chemokine receptor antagonist | 0.073 0.045 CID_851833 | CID_851833 | |
| 0.03 | 0.033 | 0.065 | 5 Hydroxytryptamine 3B antagonist | 0.065 0.01 CID_851833 | CID_851833 | |
| 0.105 | 0.108 | 0.108 | Calcium channel blocker | 0.108 0.103 CID_10114519 | CID_10114519 | |
| 0.095 | 0.099 | 0.101 | Acetylcholine release stimulant | 0.101 0.085 CID_851833 | CID_851833 | |
| 0.031 | 0.035 | 0.037 | Ceramide glucosyltransferase inhibitor | 0.037 0.022 CID_10114519 0.037 0.022 CID_851833 | CID_851833 | |
| 0.015 | 0.02 | 0.021 | 5-Alpha-reductase 2 inhibitor | 0.021 0.012 CID_56851120 | CID_56851120 | |
| 0.042 | 0.047 | 0.159 | Histamine H4 receptor antagonist | 0.159 0.004 CID_851833 | CID_851833 | |
| 0.03 | 0.035 | 0.049 | 5-Alpha-reductase inhibitor | 0.049 0.019 CID_56851120 | CID_56851120 | |
| 0.086 | 0.092 | 0.104 | Polo-like kinase-4 inhibitor | 0.098 0.08 CID_56851120 0.104 0.073 CID_851833 | CID_851833 | |
| 0.113 | 0.12 | 0.118 | Farnesoid X receptor antagonist | 0.118 0.109 CID_9847259 | CID_9847259 | |
| 0.043 | 0.051 | 0.099 | CC chemokine receptor 2B antagonist | 0.047 0.037 CID_10114519 0.099 0.005 CID_851833 | CID_851833 | |
| 0.08 | 0.089 | 0.125 | Glutamate release inhibitor | 0.125 0.019 CID_851833 | CID_851833 | |
| 0.045 | 0.056 | 0.157 | Dopamine uptake inhibitor | 0.055 0.043 CID_10114519 0.157 0.009 CID_851833 | CID_851833 | |
| 0.038 | 0.05 | 0.059 | NMDA 2A receptor antagonist | 0.059 0.03 CID_851833 | CID_851833 | |
| 0.08 | 0.092 | 0.146 | Lanosterol 14 alpha demethylase inhibitor | 0.146 0.013 CID_851833 | CID_851833 | |
| 0.025 | 0.037 | 0.07 | Kainate receptor 2 antagonist | 0.07 0.009 CID_851833 | CID_851833 | |
| 0.054 | 0.067 | 0.069 | Beta adrenoreceptor antagonist | 0.059 0.058 CID_10114519 0.066 0.045 CID_9847259 0.069 0.039 CID_56851120 | CID_56851120 | |
| 0.044 | 0.057 | 0.052 | Cyclin B2 inhibitor | 0.052 0.044 CID_851833 | CID_851833 | |
| 0.027 | 0.04 | 0.039 | Estrogen-related receptor beta antagonist | 0.032 0.023 CID_9847259 0.039 0.012 CID_851833 | CID_851833 | |
| 0.1 | 0.114 | 0.199 | Toll-Like receptor 9 antagonist | 0.199 0.036 CID_10114519 0.174 0.049 CID_851833 | CID_10114519 | |
| 0.061 | 0.076 | 0.169 | Nicotinic alpha4beta2 receptor antagonist | 0.089 0.041 CID_10114519 0.169 0.005 CID_851833 | CID_851833 | |
| 0.033 | 0.048 | 0.109 | NMDA receptor subunit 3B antagonist | 0.109 0.01 CID_851833 | CID_851833 | |
| 0.056 | 0.071 | 0.067 | Beta 2 adrenoreceptor agonist | 0.067 0.025 CID_10114519 0.065 0.033 CID_9847259 | CID_10114519 | |
| 0.035 | 0.051 | 0.052 | Cannabinoid CB2 receptor antagonist | 0.052 0.035 CID_10114519 | CID_10114519 | |
| 0.047 | 0.064 | 0.068 | Cyclin B1 inhibitor | 0.068 0.034 CID_851833 | CID_851833 | |
| 0.064 | 0.081 | 0.114 | Calcium antagonist | 0.084 0.06 CID_10114519 0.114 0.038 CID_851833 | CID_851833 | |
| 0.124 | 0.146 | 0.175 | DNA methylase inhibitor | 0.175 0.097 CID_10114519 0.165 0.104 CID_9847259 | CID_10114519 | |
| 0.052 | 0.075 | 0.103 | Cannabinoid receptor antagonist | 0.103 0.028 CID_10114519 0.078 0.041 CID_851833 | CID_10114519 | |
| 0.042 | 0.065 | 0.188 | 5 Hydroxytryptamine 6 antagonist | 0.188 0.004 CID_851833 | CID_851833 | |
| 0.063 | 0.088 | 0.085 | Androgen antagonist | 0.082 0.064 CID_9847259 0.085 0.06 CID_56851120 | CID_56851120 | |
| 0.037 | 0.062 | 0.045 | Heme oxygenase inhibitor | 0.045 0.024 CID_851833 | CID_851833 | |
| 0.063 | 0.09 | 0.087 | Estrogen receptor alpha antagonist | 0.087 0.038 CID_9847259 | CID_9847259 | |
| 0.014 | 0.042 | 0.039 | Nociceptin (N/OFQ) receptor antagonist | 0.039 0.022 CID_851833 | CID_851833 | |
| 0.04 | 0.068 | 0.054 | Cyclin B inhibitor | 0.054 0.039 CID_851833 | CID_851833 | |
| 0.092 | 0.122 | 0.133 | Interleukin 2 antagonist | 0.133 0.029 CID_9847259 0.098 0.097 CID_56851120 | CID_9847259 | |
| 0.04 | 0.071 | 0.051 | Sodium/calcium exchanger inhibitor | 0.051 0.032 CID_10114519 | CID_10114519 | |
| 0.012 | 0.043 | 0.024 | Urotensin II antagonist | 0.024 0.013 CID_851833 | CID_851833 | |
| 0.037 | 0.068 | 0.067 | Histamine agonist | 0.047 0.045 CID_10114519 0.067 0.021 CID_851833 | CID_851833 | |
| 0.119 | 0.151 | 0.16 | Anesthetic general | 0.138 0.128 CID_56851120 0.16 0.103 CID_851833 | CID_851833 | |
| 0.038 | 0.071 | 0.044 | Beta adrenoreceptor agonist | 0.044 0.038 CID_10114519 0.044 0.037 CID_9847259 | CID_9847259 | |
| 0.037 | 0.071 | 0.053 | Cannabinoid CB1 receptor agonist | 0.053 0.049 CID_851833 | CID_851833 | |
| 0.059 | 0.094 | 0.068 | Phosphodiesterase VI inhibitor | 0.068 0.067 CID_10114519 | CID_10114519 | |
| 0.033 | 0.067 | 0.05 | Potassium channel small-conductance Ca-activated blocker | 0.05 0.024 CID_851833 | CID_851833 | |
| 0.167 | 0.203 | 0.23 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.207 0.15 CID_10114519 0.23 0.125 CID_851833 | CID_851833 | |
| 0.093 | 0.129 | 0.127 | Sphingosine 1-phosphate receptor 2 agonist | 0.127 0.045 CID_851833 | CID_851833 | |
| 0.089 | 0.125 | 0.135 | Estrogen antagonist | 0.135 0.032 CID_9847259 | CID_9847259 | |
| 0.115 | 0.152 | 0.152 | DNA methyltransferase I inhibitor | 0.152 0.101 CID_10114519 0.145 0.11 CID_9847259 | CID_10114519 | |
| 0.014 | 0.052 | 0.023 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.023 0.009 CID_851833 | CID_851833 | |
| 0.069 | 0.108 | 0.076 | Ca(v)3.1 blocker | 0.076 0.073 CID_10114519 | CID_10114519 | |
| 0.067 | 0.108 | 0.143 | Chemokine receptor antagonist | 0.143 0.035 CID_851833 | CID_851833 | |
| 0.021 | 0.062 | 0.076 | NMDA receptor subunit 3A antagonist | 0.076 0.013 CID_851833 | CID_851833 | |
| 0.09 | 0.132 | 0.321 | NADPH oxidase inhibitor | 0.321 0.01 CID_56851120 0.169 0.045 CID_851833 | CID_56851120 | |
| 0.035 | 0.077 | 0.052 | Beta 1 adrenoreceptor antagonist | 0.052 0.044 CID_56851120 0.049 0.048 CID_851833 | CID_56851120 | |
| 0.023 | 0.067 | 0.058 | Vascular adhesion protein 1 inhibitor | 0.058 0.01 CID_851833 | CID_851833 | |
| 0.012 | 0.056 | 0.021 | CC chemokine 1 receptor antagonist | 0.021 0.019 CID_851833 | CID_851833 | |
| 0.008 | 0.053 | 0.019 | Cyclin D2 inhibitor | 0.019 0.004 CID_851833 | CID_851833 | |
| 0.04 | 0.084 | 0.062 | Calcium channel T-type blocker | 0.062 0.034 CID_851833 | CID_851833 | |
| 0.067 | 0.113 | 0.116 | Creatine kinase inhibitor | 0.105 0.054 CID_10114519 0.087 0.075 CID_9847259 0.116 0.044 CID_851833 | CID_851833 | |
| 0.052 | 0.099 | 0.133 | Phospholipase D inhibitor | 0.074 0.045 CID_10114519 0.133 0.004 CID_851833 | CID_851833 | |
| 0.082 | 0.131 | 0.127 | Bone formation stimulant | 0.127 0.08 CID_56851120 | CID_56851120 | |
| 0.039 | 0.09 | 0.082 | Cyclin D1 inhibitor | 0.075 0.023 CID_10114519 0.059 0.045 CID_56851120 0.082 0.016 CID_851833 | CID_851833 | |
| 0.02 | 0.071 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.019 CID_851833 | CID_851833 | |
| 0.058 | 0.11 | 0.088 | Acetylcholine agonist | 0.088 0.057 CID_851833 | CID_851833 | |
| 0.038 | 0.092 | 0.087 | Nicotinic alpha3beta2 receptor antagonist | 0.087 0.01 CID_851833 | CID_851833 | |
| 0.012 | 0.067 | 0.027 | Acetylcholine M4 receptor agonist | 0.027 0.025 CID_851833 | CID_851833 | |
| 0.065 | 0.122 | 0.074 | MAP kinase 7 inhibitor | 0.074 0.07 CID_851833 | CID_851833 | |
| 0.026 | 0.085 | 0.055 | Nicotinic receptor alpha3 subunit antagonist | 0.055 0.022 CID_851833 | CID_851833 | |
| 0.083 | 0.143 | 0.127 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.127 0.095 CID_851833 | CID_851833 | |
| 0.029 | 0.089 | 0.059 | Integrin alpha1beta1 antagonist | 0.059 0.005 CID_851833 | CID_851833 | |
| 0.155 | 0.216 | 0.215 | Cholesterol antagonist | 0.207 0.159 CID_56851120 0.215 0.152 CID_851833 | CID_851833 | |
| 0.018 | 0.081 | 0.037 | Estrogen-related receptor gamma antagonist | 0.037 0.007 CID_851833 | CID_851833 | |
| 0.063 | 0.126 | 0.138 | Falcipain 3 inhibitor | 0.138 0.043 CID_56851120 | CID_56851120 | |
| 0.079 | 0.143 | 0.193 | Ribosomal protein S6 kinase inhibitor | 0.193 0.04 CID_851833 | CID_851833 | |
| 0.024 | 0.088 | 0.043 | Acid-sensing ion channel blocker | 0.043 0.024 CID_851833 | CID_851833 | |
| 0.034 | 0.102 | 0.058 | Androgen agonist | 0.058 0.044 CID_851833 | CID_851833 | |
| 0.009 | 0.078 | 0.034 | NMDA receptor glycine site antagonist | 0.034 0.01 CID_851833 | CID_851833 | |
| 0.009 | 0.079 | 0.022 | Kainate receptor 4 antagonist | 0.022 0.02 CID_851833 | CID_851833 | |
| 0.136 | 0.209 | 0.623 | 5 Hydroxytryptamine release stimulant | 0.623 0.012 CID_851833 | CID_851833 | |
| 0.033 | 0.107 | 0.054 | Phosphodiesterase 7A inhibitor | 0.054 0.031 CID_10114519 0.052 0.035 CID_851833 | CID_10114519 | |
| 0.056 | 0.131 | 0.079 | Hepatocyte growth factor antagonist | 0.079 0.076 CID_10114519 | CID_10114519 | |
| 0.025 | 0.1 | 0.067 | Nerve growth factor antagonist | 0.067 0.006 CID_851833 | CID_851833 | |
| 0.064 | 0.14 | 0.113 | Estrogen receptor beta antagonist | 0.113 0.042 CID_9847259 | CID_9847259 | |
| 0.063 | 0.139 | 0.086 | Thioredoxin reductase inhibitor | 0.086 0.047 CID_56851120 | CID_56851120 | |
| 0.025 | 0.102 | 0.063 | Phenylethanolamine N methyltransferase inhibitor | 0.063 0.006 CID_851833 | CID_851833 | |
| 0.13 | 0.208 | 0.176 | DNA damaging | 0.176 0.139 CID_10114519 | CID_10114519 | |
| 0.047 | 0.126 | 0.152 | ALK inhibitor | 0.152 0.019 CID_851833 | CID_851833 | |
| 0.058 | 0.138 | 0.103 | Ephrin antagonist | 0.103 0.06 CID_851833 | CID_851833 | |
| 0.03 | 0.11 | 0.08 | Alpha 1L adrenoreceptor agonist | 0.08 0.004 CID_851833 | CID_851833 | |
| 0.045 | 0.126 | 0.107 | Acetylcholine nicotinic antagonist | 0.107 0.035 CID_851833 | CID_851833 | |
| 0.01 | 0.092 | 0.037 | AMPA 2 receptor antagonist | 0.037 0.016 CID_851833 | CID_851833 | |
| 0.067 | 0.151 | 0.145 | Beta glucuronidase inhibitor | 0.145 0.027 CID_851833 | CID_851833 | |
| 0.028 | 0.115 | 0.095 | Purinergic P2X4 antagonist | 0.095 0.005 CID_851833 | CID_851833 | |
| 0.034 | 0.121 | 0.097 | Neuronal nicotinic receptor antagonist | 0.097 0.026 CID_851833 | CID_851833 | |
| 0.107 | 0.194 | 0.148 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.148 0.114 CID_851833 | CID_851833 | |
| 0.023 | 0.111 | 0.08 | Dopamine transporter inhibitor | 0.08 0.017 CID_851833 | CID_851833 | |
| 0.053 | 0.141 | 0.074 | Neuropeptide Y antagonist | 0.074 0.07 CID_851833 | CID_851833 | |
| 0.017 | 0.105 | 0.053 | Cyclin D3 inhibitor | 0.053 0.02 CID_851833 | CID_851833 | |
| 0.031 | 0.12 | 0.168 | Alpha 2 adrenoreceptor agonist | 0.168 0.005 CID_851833 | CID_851833 | |
| 0.013 | 0.103 | 0.032 | Histone deacetylase class IV inhibitor | 0.032 0.021 CID_56851120 | CID_56851120 | |
| 0.013 | 0.103 | 0.032 | Histone deacetylase 11 inhibitor | 0.032 0.021 CID_56851120 | CID_56851120 | |
| 0.102 | 0.191 | 0.133 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.102 CID_10114519 0.133 0.095 CID_851833 | CID_851833 | |
| 0.132 | 0.221 | 0.403 | Superoxide dismutase inhibitor | 0.18 0.141 CID_10114519 0.21 0.107 CID_56851120 0.403 0.026 CID_851833 | CID_851833 | |
| 0.048 | 0.138 | 0.091 | Insulin like growth factor 1 antagonist | 0.091 0.049 CID_851833 | CID_851833 | |
| 0.105 | 0.197 | 0.321 | Aldehyde oxidase inhibitor | 0.321 0.061 CID_851833 | CID_851833 | |
| 0.052 | 0.145 | 0.073 | Cell adhesion molecule inhibitor | 0.073 0.064 CID_851833 | CID_851833 | |
| 0.02 | 0.115 | 0.05 | Somatostatin 4 agonist | 0.05 0.015 CID_851833 | CID_851833 | |
| 0.046 | 0.143 | 0.096 | Insulin growth factor antagonist | 0.096 0.049 CID_851833 | CID_851833 | |
| 0.027 | 0.125 | 0.075 | Nicotinic receptor alpha4 subunit antagonist | 0.075 0.015 CID_851833 | CID_851833 | |
| 0.047 | 0.146 | 0.129 | MAP-kinase-activated kinase inhibitor | 0.129 0.022 CID_851833 | CID_851833 | |
| 0.025 | 0.124 | 0.069 | CC chemokine 4 receptor antagonist | 0.069 0.01 CID_851833 | CID_851833 | |
| 0.063 | 0.164 | 0.092 | AMP-activated protein kinase stimulant | 0.092 0.082 CID_851833 | CID_851833 | |
| 0.091 | 0.193 | 0.166 | Polo-like kinase-3 inhibitor | 0.166 0.068 CID_851833 | CID_851833 | |
| 0.067 | 0.173 | 0.114 | Glutamate (mGluR7) agonist | 0.114 0.038 CID_851833 | CID_851833 | |
| 0.157 | 0.264 | 0.412 | Antiobesity | 0.412 0.061 CID_851833 | CID_851833 | |
| 0.093 | 0.2 | 0.205 | GABA C receptor rho-2 antagonist | 0.124 0.117 CID_10114519 0.131 0.104 CID_56851120 0.205 0.026 CID_851833 | CID_851833 | |
| 0.107 | 0.215 | 0.18 | ATPase inhibitor | 0.18 0.058 CID_10114519 0.158 0.089 CID_851833 | CID_10114519 | |
| 0.039 | 0.149 | 0.109 | MAP-kinase-activated kinase 2 inhibitor | 0.109 0.024 CID_851833 | CID_851833 | |
| 0.146 | 0.258 | 0.284 | Antithrombotic | 0.284 0.1 CID_56851120 | CID_56851120 | |
| 0.113 | 0.226 | 0.169 | Neurotensin receptor agonist | 0.169 0.064 CID_851833 | CID_851833 | |
| 0.069 | 0.183 | 0.576 | Aldehyde dehydrogenase inhibitor | 0.576 0.004 CID_56851120 | CID_56851120 | |
| 0.004 | 0.119 | 0.021 | Kainate receptor 1 antagonist | 0.021 0.015 CID_851833 | CID_851833 | |
| 0.051 | 0.167 | 0.082 | Caspase 7 inhibitor | 0.082 0.057 CID_851833 | CID_851833 | |
| 0.036 | 0.154 | 0.102 | Corticotropin releasing factor 2 receptor antagonist | 0.102 0.006 CID_851833 | CID_851833 | |
| 0.011 | 0.129 | 0.035 | Nicotinic acid receptor agonist | 0.035 0.026 CID_851833 | CID_851833 | |
| 0.013 | 0.135 | 0.046 | CC chemokine 3 receptor antagonist | 0.046 0.026 CID_851833 | CID_851833 | |
| 0.024 | 0.148 | 0.059 | Phosphodiesterase VII inhibitor | 0.057 0.05 CID_10114519 0.059 0.048 CID_851833 | CID_851833 | |
| 0.002 | 0.126 | 0.01 | Melatonin 5 antagonist | 0.01 0.009 CID_851833 | CID_851833 | |
| 0.182 | 0.307 | 0.247 | MAP kinase kinase 6 inhibitor | 0.247 0.195 CID_851833 | CID_851833 | |
| 0.004 | 0.13 | 0.035 | AMPA 1 receptor antagonist | 0.035 0.017 CID_851833 | CID_851833 | |
| 0.132 | 0.262 | 0.225 | Calpain 2 inhibitor | 0.221 0.17 CID_56851120 0.225 0.167 CID_851833 | CID_851833 | |
| 0.02 | 0.151 | 0.137 | Toll-Like receptor 8 antagonist | 0.137 0.004 CID_851833 | CID_851833 | |
| 0.032 | 0.162 | 0.155 | 5 Hydroxytryptamine 3 agonist | 0.155 0.005 CID_851833 | CID_851833 | |
| 0.026 | 0.157 | 0.073 | Cannabinoid CB1 receptor antagonist | 0.058 0.047 CID_10114519 0.073 0.032 CID_851833 | CID_851833 | |
| 0.165 | 0.296 | 0.202 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.202 0.161 CID_851833 | CID_851833 | |
| 0.042 | 0.18 | 0.098 | Granulocyte macrophage colony stimulating factor antagonist | 0.098 0.074 CID_851833 | CID_851833 | |
| 0.009 | 0.148 | 0.056 | Kainate receptor antagonist | 0.056 0.018 CID_851833 | CID_851833 | |
| 0.028 | 0.168 | 0.067 | Epithelial sodium channel blocker | 0.067 0.02 CID_851833 | CID_851833 | |
| 0.076 | 0.22 | 0.16 | Protein kinase (CK1) gamma 3 inhibitor | 0.16 0.079 CID_851833 | CID_851833 | |
| 0.036 | 0.181 | 0.108 | Acetylcholine nicotinic agonist | 0.108 0.032 CID_851833 | CID_851833 | |
| 0.09 | 0.239 | 0.125 | Interferon gamma antagonist | 0.125 0.122 CID_56851120 | CID_56851120 | |
| 0.077 | 0.227 | 0.119 | Aurora-C kinase inhibitor | 0.119 0.109 CID_851833 | CID_851833 | |
| 0.06 | 0.213 | 0.172 | Cytidine deaminase inhibitor | 0.172 0.061 CID_851833 | CID_851833 | |
| 0.097 | 0.249 | 0.147 | Neurotrophic factor enhancer | 0.147 0.143 CID_851833 | CID_851833 | |
| 0.011 | 0.164 | 0.049 | Glycine transporter inhibitor | 0.049 0.032 CID_851833 | CID_851833 | |
| 0.073 | 0.227 | 0.151 | Phospholipase A2 inhibitor | 0.151 0.073 CID_56851120 | CID_56851120 | |
| 0.08 | 0.235 | 0.116 | DNA repair enzyme inhibitor | 0.116 0.08 CID_10114519 | CID_10114519 | |
| 0.028 | 0.186 | 0.095 | CC chemokine receptor antagonist | 0.095 0.038 CID_851833 | CID_851833 | |
| 0.026 | 0.184 | 0.081 | Protein kinase C beta inhibitor | 0.081 0.029 CID_851833 | CID_851833 | |
| 0.089 | 0.25 | 0.154 | Pregnane X receptor agonist | 0.154 0.046 CID_851833 | CID_851833 | |
| 0.009 | 0.174 | 0.031 | Myristoyl transferase inhibitor | 0.031 0.012 CID_851833 | CID_851833 | |
| 0.059 | 0.225 | 0.134 | Cyclooxygenase 3 inhibitor | 0.134 0.062 CID_851833 | CID_851833 | |
| 0.029 | 0.197 | 0.067 | Glucosylceramidase inhibitor | 0.067 0.024 CID_851833 | CID_851833 | |
| 0.035 | 0.203 | 0.125 | Glycine receptor antagonist | 0.125 0.016 CID_851833 | CID_851833 | |
| 0.029 | 0.202 | 0.061 | Alpha 1b adrenoreceptor agonist | 0.061 0.018 CID_851833 | CID_851833 | |
| 0.018 | 0.19 | 0.072 | Nicotinic neuronal receptor agonist | 0.072 0.026 CID_851833 | CID_851833 | |
| 0.033 | 0.206 | 0.076 | Protein kinase B gamma inhibitor | 0.076 0.05 CID_851833 | CID_851833 | |
| 0.024 | 0.197 | 0.061 | Check point kinase 1 inhibitor | 0.061 0.057 CID_851833 | CID_851833 | |
| 0.103 | 0.278 | 0.145 | Catenin beta inhibitor | 0.145 0.117 CID_851833 | CID_851833 | |
| 0.016 | 0.191 | 0.06 | Histone deacetylase 9 inhibitor | 0.06 0.012 CID_56851120 | CID_56851120 | |
| 0.024 | 0.203 | 0.08 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.08 0.05 CID_851833 | CID_851833 | |
| 0.076 | 0.256 | 0.121 | Sphingosine 1-phosphate receptor 2 antagonist | 0.121 0.094 CID_851833 | CID_851833 | |
| 0.018 | 0.201 | 0.058 | Nicotinic receptor alpha7 subunit antagonist | 0.058 0.031 CID_851833 | CID_851833 | |
| 0.01 | 0.193 | 0.032 | Acid ceramidase inhibitor | 0.032 0.007 CID_851833 | CID_851833 | |
| 0.011 | 0.195 | 0.057 | Dopamine D5 agonist | 0.057 0.013 CID_851833 | CID_851833 | |
| 0.023 | 0.207 | 0.084 | Toll-Like receptor 7 antagonist | 0.084 0.034 CID_851833 | CID_851833 | |
| 0.015 | 0.2 | 0.038 | Melatonin receptor 1A agonist | 0.038 0.016 CID_56851120 | CID_56851120 | |
| 0.038 | 0.223 | 0.122 | Protein kinase C delta inhibitor | 0.122 0.035 CID_851833 | CID_851833 | |
| 0.025 | 0.211 | 0.082 | Protein kinase C alpha inhibitor | 0.082 0.033 CID_851833 | CID_851833 | |
| 0.009 | 0.196 | 0.042 | AMPA receptor antagonist | 0.042 0.041 CID_851833 | CID_851833 | |
| 0.015 | 0.204 | 0.045 | AMPA 4 receptor antagonist | 0.045 0.02 CID_851833 | CID_851833 | |
| 0.031 | 0.221 | 0.12 | Protein kinase (CK2) alpha inhibitor | 0.12 0.062 CID_851833 | CID_851833 | |
| 0.022 | 0.214 | 0.075 | Cyclin-dependent kinase 4 inhibitor | 0.075 0.038 CID_851833 | CID_851833 | |
| 0.049 | 0.241 | 0.188 | ABCA1 expression enhancer | 0.188 0.011 CID_56851120 | CID_56851120 | |
| 0.012 | 0.206 | 0.05 | Stearoyl-CoA desaturase inhibitor | 0.05 0.023 CID_851833 | CID_851833 | |
| 0.005 | 0.199 | 0.029 | Histamine H4 receptor agonist | 0.029 0.007 CID_851833 | CID_851833 | |
| 0.012 | 0.207 | 0.031 | Thymidine phosphorylase inhibitor | 0.031 0.011 CID_851833 | CID_851833 | |
| 0.092 | 0.287 | 0.234 | Phospholipase C inhibitor | 0.234 0.029 CID_851833 | CID_851833 | |
| 0.007 | 0.202 | 0.032 | AMPA 3 receptor antagonist | 0.032 0.019 CID_851833 | CID_851833 | |
| 0.004 | 0.202 | 0.053 | Nicotinic alpha4 receptor agonist | 0.053 0.004 CID_851833 | CID_851833 | |
| 0.129 | 0.329 | 0.2 | Apoptosis antagonist | 0.2 0.179 CID_56851120 | CID_56851120 | |
| 0.025 | 0.227 | 0.046 | Bombesin 2 receptor antagonist | 0.046 0.04 CID_851833 | CID_851833 | |
| 0.027 | 0.231 | 0.075 | Protein kinase A inhibitor | 0.075 0.065 CID_851833 | CID_851833 | |
| 0.015 | 0.22 | 0.094 | NMDA receptor glycine site agonist | 0.094 0.02 CID_851833 | CID_851833 | |
| 0.052 | 0.259 | 0.092 | Alpha 2d adrenoreceptor antagonist | 0.092 0.067 CID_851833 | CID_851833 | |
| 0.016 | 0.222 | 0.064 | CDK4/cyclin D1 inhibitor | 0.064 0.036 CID_851833 | CID_851833 | |
| 0.035 | 0.242 | 0.064 | Histone deacetylase SIRT3 inhibitor | 0.064 0.038 CID_851833 | CID_851833 | |
| 0.134 | 0.342 | 0.304 | Analgesic | 0.304 0.139 CID_851833 | CID_851833 | |
| 0.027 | 0.235 | 0.057 | Heat shock protein 90 beta antagonist | 0.057 0.045 CID_851833 | CID_851833 | |
| 0.015 | 0.223 | 0.054 | CC chemokine 2 receptor antagonist | 0.054 0.039 CID_851833 | CID_851833 | |
| 0.07 | 0.278 | 0.261 | MAP kinase kinase 2 inhibitor | 0.261 0.049 CID_851833 | CID_851833 | |
| 0.105 | 0.314 | 0.145 | Ca2+-transporting ATPase inhibitor | 0.145 0.057 CID_851833 | CID_851833 | |
| 0.126 | 0.338 | 0.279 | Tyrosine 3 hydroxylase inhibitor | 0.186 0.162 CID_56851120 0.279 0.045 CID_851833 | CID_851833 | |
| 0.041 | 0.253 | 0.086 | GABA B receptor agonist | 0.086 0.031 CID_851833 | CID_851833 | |
| 0.021 | 0.234 | 0.061 | Sphingosine kinase 2 inhibitor | 0.061 0.031 CID_851833 | CID_851833 | |
| 0.005 | 0.221 | 0.046 | Imidazoline I1 receptor antagonist | 0.046 0.004 CID_851833 | CID_851833 | |
| 0.014 | 0.231 | 0.041 | Dihydrofolate reductase inhibitor | 0.041 0.038 CID_851833 | CID_851833 | |
| 0.027 | 0.244 | 0.103 | Check point kinase 2 inhibitor | 0.103 0.063 CID_851833 | CID_851833 | |
| 0.01 | 0.228 | 0.048 | Glutamate (mGluR5) agonist | 0.048 0.028 CID_851833 | CID_851833 | |
| 0.118 | 0.336 | 0.236 | Insulysin inhibitor | 0.236 0.11 CID_851833 | CID_851833 | |
| 0.015 | 0.235 | 0.052 | Protein kinase C theta inhibitor | 0.052 0.05 CID_851833 | CID_851833 | |
| 0.05 | 0.271 | 0.171 | Activin receptor-like kinase 2 inhibitor | 0.171 0.052 CID_851833 | CID_851833 | |
| 0.043 | 0.266 | 0.294 | Amylase inhibitor | 0.294 0.019 CID_56851120 | CID_56851120 | |
| 0.042 | 0.266 | 0.109 | Bromodomain-containing protein 2 inhibitor | 0.109 0.032 CID_851833 | CID_851833 | |
| 0.054 | 0.278 | 0.08 | CC chemokine 5 receptor agonist | 0.08 0.063 CID_851833 | CID_851833 | |
| 0.014 | 0.239 | 0.055 | CDK4/cyclin D inhibitor | 0.055 0.046 CID_851833 | CID_851833 | |
| 0.015 | 0.243 | 0.066 | EphB4 antagonist | 0.066 0.033 CID_851833 | CID_851833 | |
| 0.071 | 0.301 | 0.136 | Adenylate cyclase stimulant | 0.136 0.089 CID_851833 | CID_851833 | |
| 0.041 | 0.271 | 0.095 | MAP kinase kinase 1 inhibitor | 0.095 0.064 CID_851833 | CID_851833 | |
| 0.021 | 0.253 | 0.073 | Nav1.8 sodium channel blocker | 0.073 0.052 CID_10114519 | CID_10114519 | |
| 0.037 | 0.271 | 0.112 | Alkylator | 0.112 0.076 CID_56851120 | CID_56851120 | |
| 0.054 | 0.292 | 0.143 | Interleukin 8 antagonist | 0.143 0.039 CID_851833 | CID_851833 | |
| 0.022 | 0.26 | 0.115 | Protein kinase (CK2) inhibitor | 0.115 0.051 CID_851833 | CID_851833 | |
| 0.007 | 0.246 | 0.026 | Calcium-sensing receptor agonist | 0.026 0.019 CID_851833 | CID_851833 | |
| 0.008 | 0.252 | 0.059 | Glutamate (mGluR1) antagonist | 0.059 0.04 CID_851833 | CID_851833 | |
| 0.025 | 0.271 | 0.064 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.064 0.036 CID_851833 | CID_851833 | |
| 0.009 | 0.262 | 0.045 | Glutamate (mGluR group I) agonist | 0.045 0.037 CID_851833 | CID_851833 | |
| 0.006 | 0.262 | 0.114 | Potassium channel small-conductance Ca-activated activator | 0.114 0.004 CID_851833 | CID_851833 | |
| 0.056 | 0.314 | 0.183 | I kappa B kinase epsilon inhibitor | 0.183 0.086 CID_851833 | CID_851833 | |
| 0.048 | 0.308 | 0.114 | Hedgehog signaling inhibitor | 0.114 0.045 CID_851833 | CID_851833 | |
| 0.051 | 0.311 | 0.08 | Transforming growth factor beta 3 antagonist | 0.08 0.065 CID_851833 | CID_851833 | |
| 0.04 | 0.301 | 0.14 | Electrolyte absorption antagonist | 0.14 0.023 CID_851833 | CID_851833 | |
| 0.031 | 0.294 | 0.136 | Protein kinase C mu inhibitor | 0.136 0.033 CID_851833 | CID_851833 | |
| 0.012 | 0.283 | 0.051 | Histamine H1 receptor agonist | 0.051 0.017 CID_851833 | CID_851833 | |
| 0.006 | 0.279 | 0.02 | Alpha 2d adrenoreceptor agonist | 0.02 0.018 CID_851833 | CID_851833 | |
| 0.004 | 0.278 | 0.044 | Nicotinic alpha4beta2 receptor agonist | 0.044 0.006 CID_851833 | CID_851833 | |
| 0.035 | 0.324 | 0.122 | Sodium channel blocker | 0.122 0.082 CID_851833 | CID_851833 | |
| 0.044 | 0.333 | 0.108 | Photosensitizer | 0.108 0.074 CID_56851120 | CID_56851120 | |
| 0.022 | 0.313 | 0.053 | Pregnane X receptor antagonist | 0.053 0.05 CID_851833 | CID_851833 | |
| 0.013 | 0.304 | 0.032 | Vanilloid 4 antagonist | 0.032 0.023 CID_851833 | CID_851833 | |
| 0.023 | 0.315 | 0.131 | Pim-3 kinase inhibitor | 0.131 0.025 CID_851833 | CID_851833 | |
| 0.038 | 0.333 | 0.097 | Phosphodiesterase 7B inhibitor | 0.097 0.06 CID_851833 | CID_851833 | |
| 0.064 | 0.362 | 0.129 | MAP kinase 3 inhibitor | 0.129 0.11 CID_851833 | CID_851833 | |
| 0.023 | 0.322 | 0.124 | Potassium channel (Ca-activated) activator | 0.124 0.039 CID_851833 | CID_851833 | |
| 0.098 | 0.402 | 0.137 | Heat shock protein 70 antagonist | 0.137 0.085 CID_851833 | CID_851833 | |
| 0.019 | 0.323 | 0.073 | NMDA receptor agonist | 0.073 0.034 CID_851833 | CID_851833 | |
| 0.029 | 0.337 | 0.063 | Caspase 9 inhibitor | 0.063 0.042 CID_56851120 | CID_56851120 | |
| 0.032 | 0.341 | 0.157 | GABA C receptor rho-1 antagonist | 0.157 0.018 CID_851833 | CID_851833 | |
| 0.008 | 0.319 | 0.034 | Histone deacetylase 7 inhibitor | 0.034 0.028 CID_56851120 | CID_56851120 | |
| 0.035 | 0.355 | 0.088 | MAP kinase kinase 7 inhibitor | 0.088 0.027 CID_851833 | CID_851833 | |
| 0.013 | 0.338 | 0.183 | Catalase inhibitor | 0.183 0.019 CID_56851120 | CID_56851120 | |
| 0.028 | 0.355 | 0.138 | Sodium channel (voltage-gated) blocker | 0.138 0.064 CID_851833 | CID_851833 | |
| 0.004 | 0.331 | 0.045 | Nicotinic alpha3beta4 receptor agonist | 0.045 0.007 CID_851833 | CID_851833 | |
| 0.044 | 0.374 | 0.177 | Immunostimulant | 0.177 0.135 CID_56851120 | CID_56851120 | |
| 0.004 | 0.335 | 0.048 | Methionyl aminopeptidase 1 inhibitor | 0.048 0.007 CID_851833 | CID_851833 | |
| 0.004 | 0.337 | 0.036 | Calpain 1 inhibitor | 0.036 0.017 CID_56851120 | CID_56851120 | |
| 0.07 | 0.404 | 0.248 | DNA synthesis inhibitor | 0.192 0.136 CID_56851120 0.248 0.068 CID_851833 | CID_851833 | |
| 0.017 | 0.358 | 0.096 | Pim-1 kinase inhibitor | 0.096 0.062 CID_851833 | CID_851833 | |
| 0.055 | 0.397 | 0.188 | Succinate dehydrogenase inhibitor | 0.188 0.06 CID_56851120 0.178 0.07 CID_851833 | CID_56851120 | |
| 0.05 | 0.393 | 0.183 | Calpain inhibitor | 0.183 0.131 CID_56851120 | CID_56851120 | |
| 0.026 | 0.371 | 0.071 | Glycine receptor agonist | 0.071 0.052 CID_851833 | CID_851833 | |
| 0.099 | 0.447 | 0.222 | Nitric-oxide synthase stimulant | 0.222 0.058 CID_851833 | CID_851833 | |
| 0.025 | 0.374 | 0.173 | GABA C receptor antagonist | 0.173 0.02 CID_851833 | CID_851833 | |
| 0.045 | 0.394 | 0.101 | CDK3/cyclin E inhibitor | 0.101 0.085 CID_851833 | CID_851833 | |
| 0.018 | 0.37 | 0.063 | Cyclin H inhibitor | 0.063 0.035 CID_851833 | CID_851833 | |
| 0.01 | 0.363 | 0.063 | Pim-2 kinase inhibitor | 0.063 0.028 CID_851833 | CID_851833 | |
| 0.042 | 0.395 | 0.158 | Cyclin-dependent kinase 8 inhibitor | 0.158 0.072 CID_851833 | CID_851833 | |
| 0.005 | 0.36 | 0.044 | 5 Hydroxytryptamine 6 agonist | 0.044 0.006 CID_851833 | CID_851833 | |
| 0.039 | 0.401 | 0.131 | TRPA1 agonist | 0.131 0.046 CID_56851120 | CID_56851120 | |
| 0.023 | 0.386 | 0.139 | Cystathionine beta-synthase inhibitor | 0.139 0.046 CID_851833 | CID_851833 | |
| 0.053 | 0.416 | 0.209 | 3C-like protease (Human coronavirus) inhibitor | 0.209 0.047 CID_851833 | CID_851833 | |
| 0.025 | 0.39 | 0.12 | UDP-glucose 4-epimerase inhibitor | 0.118 0.044 CID_56851120 0.12 0.043 CID_851833 | CID_851833 | |
| 0.017 | 0.393 | 0.044 | CF transmembrane conductance regulator antagonist | 0.044 0.015 CID_851833 | CID_851833 | |
| 0.059 | 0.441 | 0.237 | Transcription factor NF kappa B inhibitor | 0.237 0.137 CID_56851120 | CID_56851120 | |
| 0.01 | 0.393 | 0.041 | GABA B receptor antagonist | 0.041 0.033 CID_851833 | CID_851833 | |
| 0.016 | 0.402 | 0.069 | Aryl hydrocarbon receptor antagonist | 0.069 0.038 CID_851833 | CID_851833 | |
| 0.051 | 0.44 | 0.18 | Lipoxygenase inhibitor | 0.18 0.164 CID_56851120 | CID_56851120 | |
| 0.025 | 0.414 | 0.124 | Caspase 3 inhibitor | 0.124 0.055 CID_56851120 | CID_56851120 | |
| 0.044 | 0.436 | 0.166 | Hexokinase inhibitor | 0.166 0.061 CID_851833 | CID_851833 | |
| 0.009 | 0.401 | 0.068 | Cyclin A1 inhibitor | 0.068 0.025 CID_851833 | CID_851833 | |
| 0.075 | 0.471 | 0.194 | RNA-directed DNA polymerase inhibitor | 0.194 0.108 CID_851833 | CID_851833 | |
| 0.028 | 0.425 | 0.122 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.122 0.038 CID_851833 | CID_851833 | |
| 0.008 | 0.409 | 0.08 | Cyclin-dependent kinase 6 inhibitor | 0.08 0.022 CID_851833 | CID_851833 | |
| 0.036 | 0.439 | 0.096 | D-Ala-D-Ala ligase inhibitor | 0.096 0.034 CID_851833 | CID_851833 | |
| 0.024 | 0.431 | 0.111 | Cyclin-dependent kinase 7 inhibitor | 0.111 0.092 CID_851833 | CID_851833 | |
| 0.022 | 0.431 | 0.11 | Interleukin 1 beta converting enzyme inhibitor | 0.11 0.045 CID_56851120 | CID_56851120 | |
| 0.01 | 0.42 | 0.036 | Tryptophan 5 hydroxylase inhibitor | 0.036 0.023 CID_851833 | CID_851833 | |
| 0.016 | 0.426 | 0.062 | Protease 3C (Human rhinovirus) inhibitor | 0.062 0.049 CID_56851120 | CID_56851120 | |
| 0.003 | 0.429 | 0.029 | Endothelin B receptor antagonist | 0.029 0.009 CID_56851120 | CID_56851120 | |
| 0.002 | 0.428 | 0.021 | Cyclin T1 inhibitor | 0.021 0.01 CID_851833 | CID_851833 | |
| 0.032 | 0.467 | 0.119 | Activin receptor-like kinase 4 inhibitor | 0.119 0.053 CID_851833 | CID_851833 | |
| 0.029 | 0.468 | 0.082 | Granulocyte macrophage colony stimulating factor agonist | 0.082 0.069 CID_56851120 | CID_56851120 | |
| 0.038 | 0.479 | 0.11 | 3C-Like protease (SARS coronavirus) inhibitor | 0.11 0.025 CID_56851120 | CID_56851120 | |
| 0.047 | 0.492 | 0.135 | CF transmembrane conductance regulator agonist | 0.135 0.106 CID_851833 | CID_851833 | |
| 0.033 | 0.482 | 0.174 | Peroxidase inhibitor | 0.174 0.067 CID_851833 | CID_851833 | |
| 0.016 | 0.467 | 0.142 | LIM domain kinase 1 inhibitor | 0.142 0.106 CID_851833 | CID_851833 | |
| 0.04 | 0.491 | 0.147 | Transcription factor STAT6 inhibitor | 0.147 0.026 CID_851833 | CID_851833 | |
| 0.027 | 0.479 | 0.113 | NADH dehydrogenase inhibitor | 0.113 0.033 CID_851833 | CID_851833 | |
| 0.016 | 0.468 | 0.087 | Potassium channel activator | 0.087 0.065 CID_851833 | CID_851833 | |
| 0.004 | 0.46 | 0.022 | Alpha 2b adrenoreceptor agonist | 0.022 0.008 CID_851833 | CID_851833 | |
| 0.05 | 0.508 | 0.209 | Hypoxia-inducible factor 1 alpha inhibitor | 0.209 0.141 CID_851833 | CID_851833 | |
| 0.008 | 0.466 | 0.043 | Protein kinase (CK2) beta inhibitor | 0.043 0.01 CID_851833 | CID_851833 | |
| 0.048 | 0.507 | 0.182 | Factor V inhibitor | 0.182 0.008 CID_56851120 | CID_56851120 | |
| 0.021 | 0.48 | 0.082 | Exportin-1 inhibitor | 0.082 0.023 CID_851833 | CID_851833 | |
| 0.025 | 0.494 | 0.122 | Mannose-6-phosphate isomerase inhibitor | 0.122 0.097 CID_851833 | CID_851833 | |
| 0.006 | 0.479 | 0.07 | Nav1.7 sodium channel blocker | 0.07 0.043 CID_851833 | CID_851833 | |
| 0.022 | 0.499 | 0.13 | HIV-1 integrase (Overall Integration) inhibitor | 0.13 0.034 CID_851833 | CID_851833 | |
| 0.094 | 0.573 | 0.377 | 5 Hydroxytryptamine uptake stimulant | 0.377 0.019 CID_851833 | CID_851833 | |
| 0.011 | 0.498 | 0.047 | Dopamine beta hydroxylase inhibitor | 0.047 0.038 CID_851833 | CID_851833 | |
| 0.024 | 0.513 | 0.085 | Vanilloid 4 agonist | 0.085 0.033 CID_851833 | CID_851833 | |
| 0.011 | 0.508 | 0.082 | Alcohol dehydrogenase inhibitor | 0.082 0.077 CID_56851120 | CID_56851120 | |
| 0.003 | 0.52 | 0.038 | Diamine oxidase inhibitor | 0.038 0.026 CID_851833 | CID_851833 | |
| 0.002 | 0.525 | 0.021 | Alpha 2c adrenoreceptor agonist | 0.021 0.009 CID_851833 | CID_851833 | |
| 0.021 | 0.546 | 0.09 | Triose-phosphate isomerase inhibitor | 0.09 0.06 CID_56851120 | CID_56851120 | |
| 0.032 | 0.56 | 0.128 | Melanin inhibitor | 0.128 0.118 CID_56851120 | CID_56851120 | |
| 0.003 | 0.549 | 0.039 | Protein kinase (CK1) epsilon inhibitor | 0.039 0.028 CID_851833 | CID_851833 | |
| 0.006 | 0.563 | 0.034 | Integrin alpha2 antagonist | 0.034 0.032 CID_851833 | CID_851833 | |
| 0.031 | 0.592 | 0.102 | Adenylate kinase inhibitor | 0.102 0.064 CID_56851120 | CID_56851120 | |
| 0.004 | 0.569 | 0.058 | Alpha 1d adrenoreceptor agonist | 0.058 0.012 CID_851833 | CID_851833 | |
| 0.01 | 0.578 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.03 CID_851833 | CID_851833 | |
| 0.013 | 0.59 | 0.169 | Ferrochelatase inhibitor | 0.169 0.031 CID_851833 | CID_851833 | |
| 0.007 | 0.594 | 0.05 | Potassium channel (Inward rectifier) activator | 0.05 0.035 CID_851833 | CID_851833 | |
| 0.013 | 0.6 | 0.199 | GABA C receptor agonist | 0.199 0.02 CID_851833 | CID_851833 | |
| 0.001 | 0.589 | 0.031 | Alpha 2a adrenoreceptor agonist | 0.031 0.005 CID_851833 | CID_851833 | |
| 0.007 | 0.598 | 0.048 | Potassium channel (ATP-sensitive) activator | 0.048 0.034 CID_851833 | CID_851833 | |
| 0.013 | 0.65 | 0.148 | Alpha-N-acetylglucosaminidase inhibitor | 0.123 0.075 CID_56851120 0.148 0.056 CID_851833 | CID_851833 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |